- Supported exchanges /
- F /
- 27F0.F
Kala Pharmaceuticals Inc (27F0 F) stock market data APIs
KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Kala Pharmaceuticals Inc Financial Data Overview
| 6.455 | |
| 6.52 | |
| - | |
| 6.52 | |
| 6.455 | |
| 4.224-8.615 | |
| 35 734 K | |
| 5 481 K | |
| 0 | |
| -2.127 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Kala Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -40 978 000
- Earnings Per Share -12.52
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Kala Pharmaceuticals Inc Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Kala Pharmaceuticals Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
